Radiopharm Theranostics Ltd ADR (RADX)

$16.19 +10.59 (189.11%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; a...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
RadioIsotope25
RadioIsotope25 Apr. 4 at 5:34 PM
$RADX Radiopharm Theranostics ), 2566.66% surge in interest Spruce Biosciences ), 280.31% surge in interest Summit Therapeutics ), 197.53% surge in interest $SPRB $SMMT
1 · Reply
RadioIsotope25
RadioIsotope25 Apr. 4 at 12:17 PM
$RADX Cheapest Valuation - $50 mil mkt cap Most expensive Neighborhood (Radiopharma Valuations) Best lineage (ceo comes from $NVS Top pipeline science coming from #1 Md anderson in b7-h3 and $AKTS has similar drug trading at $1 bil mkt cap Rad-101 fda fast tracker would be 3rd largest radio-imaging agent. Hitting 90% and would bring in a mountain of cash non-dilutive after June data $LNTH owns 15% and love imaging. They worth $5+ billion Her2 is hot Novartis just bought phase 1/2 asset for $1-2 billion. Rad202 call option to that if data keeps progressing
0 · Reply
cor1
cor1 Apr. 3 at 10:01 PM
$RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 3 at 9:36 PM
She likes RAD101 news on LinkedIn. Hopefully she has some pull at $RADX maybe she’s keeping an eye on company for RAD202…
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 3 at 12:41 PM
$RADX
0 · Reply
johnday888
johnday888 Apr. 3 at 12:14 AM
$RADX behaving like i expected trading between 4 -4.5 👍 we wait for may
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 2 at 10:24 PM
$RADX How the Novartis deal connects to RAD202 1. 💸 Confirms BIG money for oncology therapeutics Novartis just paid: $2B upfront for Phase 1/2 drug 👉 That’s huge for early-stage What that means for RAD202: Validates that early clinical oncology assets = very valuable If RAD202 shows: meaningful uptake ORR (20–30% like you’re modeling) 👉 You’re in the same “early-stage value creation” bucket
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 2 at 10:21 PM
HER2 is HOT. Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline | Novartis $RADX https://www.novartis.com/news/media-releases/novartis-agrees-acquire-pan-mutant-selective-pi3ka-inhibitor-strengthening-its-breast-cancer-pipeline
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 2 at 10:19 PM
Novartis shells out $2 billion for immunology biotech Excellergy $RADX https://www.cnbc.com/2026/03/27/novartis-nvs-stock-excellergy-buy-biotech-deal.html
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 2 at 10:15 PM
Merck’s $6.7B Terns Acquisition Positions It to Challenge a Blockbuster Novartis Cancer Drug - Dealbreaker $RADX https://medcitynews.com/2026/03/merck-terns-pharma-acquisition-cancer-chronic-myeloid-leukemia-cml-tern-mrk/
0 · Reply
Latest News on RADX
Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

Fri, 27 Mar 2026 07:00:00 -0400 - 9 days ago

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

Radiopharm Theranostics Eyes Pivotal Trial Path After Encouraging Interim Results

Tue, 24 Mar 2026 10:56:48 -0400 - 12 days ago

Radiopharm Theranostics Eyes Pivotal Trial Path After Encouraging Interim Results

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

Wed, 28 Jan 2026 07:00:00 -0500 - 2 months ago

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Mon, 12 Jan 2026 07:00:00 -0500 - 2 months ago

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Mon, 15 Dec 2025 11:59:59 -0500 - 3 months ago

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Mon, 15 Dec 2025 07:00:00 -0500 - 3 months ago

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Radiopharm Theranostics (RADX): Analyst Maintains 'Buy' as Price Target Adjusts | RADX Stock News

2025-11-26T18:34:17.000Z - 4 months ago

Radiopharm Theranostics (RADX): Analyst Maintains 'Buy' as Price Target Adjusts | RADX Stock News

Lantheus (LNTH) Commits to Significant Investment in Radiopharm Theranostics

2025-10-20T13:30:38.000Z - 5 months ago

Lantheus (LNTH) Commits to Significant Investment in Radiopharm Theranostics

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Mon, 20 Oct 2025 07:30:00 -0400 - 5 months ago

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Regal-backed biotech Radiopharm Theranostics launches $35m placement

2025-10-15T23:01:20.000Z - 6 months ago

Regal-backed biotech Radiopharm Theranostics launches $35m placement

Radiopharm Theranostics Limited - Special Call

Tue, 02 Sep 2025 01:15:35 -0400 - 7 months ago

Radiopharm Theranostics Limited - Special Call

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Tue, 29 Jul 2025 07:30:00 -0400 - 8 months ago

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Tue, 22 Jul 2025 08:00:00 -0400 - 9 months ago

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Mon, 02 Jun 2025 08:00:00 -0400 - 10 months ago

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Mon, 19 May 2025 08:00:00 -0400 - 11 months ago

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

2025-03-12T16:57:48.000Z - 1 year ago

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

Mon, 30 Dec 2024 08:00:00 -0500 - 1 year ago

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Fri, 20 Dec 2024 08:00:00 -0500 - 1 year ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

Thu, 19 Sep 2024 12:00:00 -0400 - 1 year ago

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

RadioIsotope25
RadioIsotope25 Apr. 4 at 5:34 PM
$RADX Radiopharm Theranostics ), 2566.66% surge in interest Spruce Biosciences ), 280.31% surge in interest Summit Therapeutics ), 197.53% surge in interest $SPRB $SMMT
1 · Reply
RadioIsotope25
RadioIsotope25 Apr. 4 at 12:17 PM
$RADX Cheapest Valuation - $50 mil mkt cap Most expensive Neighborhood (Radiopharma Valuations) Best lineage (ceo comes from $NVS Top pipeline science coming from #1 Md anderson in b7-h3 and $AKTS has similar drug trading at $1 bil mkt cap Rad-101 fda fast tracker would be 3rd largest radio-imaging agent. Hitting 90% and would bring in a mountain of cash non-dilutive after June data $LNTH owns 15% and love imaging. They worth $5+ billion Her2 is hot Novartis just bought phase 1/2 asset for $1-2 billion. Rad202 call option to that if data keeps progressing
0 · Reply
cor1
cor1 Apr. 3 at 10:01 PM
$RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 3 at 9:36 PM
She likes RAD101 news on LinkedIn. Hopefully she has some pull at $RADX maybe she’s keeping an eye on company for RAD202…
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 3 at 12:41 PM
$RADX
0 · Reply
johnday888
johnday888 Apr. 3 at 12:14 AM
$RADX behaving like i expected trading between 4 -4.5 👍 we wait for may
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 2 at 10:24 PM
$RADX How the Novartis deal connects to RAD202 1. 💸 Confirms BIG money for oncology therapeutics Novartis just paid: $2B upfront for Phase 1/2 drug 👉 That’s huge for early-stage What that means for RAD202: Validates that early clinical oncology assets = very valuable If RAD202 shows: meaningful uptake ORR (20–30% like you’re modeling) 👉 You’re in the same “early-stage value creation” bucket
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 2 at 10:21 PM
HER2 is HOT. Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline | Novartis $RADX https://www.novartis.com/news/media-releases/novartis-agrees-acquire-pan-mutant-selective-pi3ka-inhibitor-strengthening-its-breast-cancer-pipeline
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 2 at 10:19 PM
Novartis shells out $2 billion for immunology biotech Excellergy $RADX https://www.cnbc.com/2026/03/27/novartis-nvs-stock-excellergy-buy-biotech-deal.html
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 2 at 10:15 PM
Merck’s $6.7B Terns Acquisition Positions It to Challenge a Blockbuster Novartis Cancer Drug - Dealbreaker $RADX https://medcitynews.com/2026/03/merck-terns-pharma-acquisition-cancer-chronic-myeloid-leukemia-cml-tern-mrk/
0 · Reply
YungnredE
YungnredE Apr. 2 at 7:59 PM
$RADX this is good for flipping... the only stock thats guaranteed to drop to $4 and rise to $4.30 every day.
1 · Reply
RadioIsotope25
RadioIsotope25 Apr. 2 at 12:55 PM
$RADX War going to end soon. Just in time for hot off the press final rad101 data.. Make sure you’re positioned in high octane winners for the big bounce.
1 · Reply
RadioIsotope25
RadioIsotope25 Apr. 2 at 2:10 AM
$RADX
0 · Reply
trichomy
trichomy Apr. 2 at 12:44 AM
$ARTL $INMB $PYXS $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 1 at 11:38 PM
$RADX ChatGPT’s interpretation of her liking news Bottom line Lantheus = floor buyer Novartis = upside optionality Your LinkedIn find = early signal RAD101 is being watched broadly 👉 Which supports your thesis: This isn’t dead money — it’s just waiting on the catalyst
0 · Reply
Manpreet00
Manpreet00 Apr. 1 at 7:57 PM
$RADX looks like accumulation to me
1 · Reply
RadioIsotope25
RadioIsotope25 Apr. 1 at 5:25 PM
Wow this is a huge like by head of portfolio at NVS on RAD101 92% news on LinkedIn on its phase 2b data. She’s at Novartis they are the biggest dealmaker in the space. $RADX
3 · Reply
RadioIsotope25
RadioIsotope25 Apr. 1 at 5:19 PM
Professor Jason Lewis: the rise of radiopharmaceuticals - Australian Institute for Bioengineering and Nanotechnology - University of Queensland $RADX https://aibn.uq.edu.au/article/2026/03/professor-jason-lewis-rise-radiopharmaceuticals
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 1 at 1:40 PM
Stonepine Capital Management LLC Portfolio | Stonepine Capital Management LLC 13F Holdings & Trades Owns 163,000 RADX $RADX https://hedgefollow.com/funds/Stonepine+Capital+Management+LLC
0 · Reply
watchaddict
watchaddict Apr. 1 at 1:00 PM
$RADX adding
0 · Reply
YungnredE
YungnredE Mar. 31 at 7:30 PM
$RADX Seems like the whole market is green while this continues to be stagnant.... smh
3 · Reply
th3_fail_k1ng
th3_fail_k1ng Mar. 31 at 5:54 PM
$RADX holding 1000 shares at $5 avc through April and then a speculative acquisition announcement. Pretty sure I'll bank well but my portfolio is not liking this red when the rest is green. Holding like a good lil baggie
2 · Reply